Delivery of RNA Interference
Li, Charles X, Parker, Amy, Menocal, Ellen, Xiang, Shuanglin, Borodyansky, Laura, Fruehauf, Johannes H.
Published in Cell cycle (Georgetown, Tex.) (15.09.2006)
Published in Cell cycle (Georgetown, Tex.) (15.09.2006)
Get full text
Journal Article
Fat Polyp, Thin Blood: Think Clip
Borodyansky, Laura, MD, Saltzman, John R., MD
Published in Clinical gastroenterology and hepatology (01.10.2013)
Published in Clinical gastroenterology and hepatology (01.10.2013)
Get full text
Journal Article
Randomized, Double-Blind, Placebo-Controlled Phase III Study of Paclitaxel ± Napabucasin in Pretreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Shah, Manish A, Shitara, Kohei, Lordick, Florian, Bang, Yung-Jue, Tebbutt, Niall C, Metges, Jean-Phillippe, Muro, Kei, Lee, Keun-Wook, Shen, Lin, Tjulandin, Sergei, Hays, John L, Starling, Naureen, Xu, Rui-Hua, Sturtz, Keren, Fontaine, Marilyn, Oh, Cindy, Brooks, Emily M, Xu, Bo, Li, Wei, Li, Chiang J, Borodyansky, Laura, Van Cutsem, Eric
Published in Clinical cancer research (01.09.2022)
Published in Clinical cancer research (01.09.2022)
Get full text
Journal Article
The BRIGHTER trial: A phase III randomized double-blind study of BBI-608 + weekly paclitaxel versus placebo (PBO) + weekly paclitaxel in patients (pts) with pretreated advanced gastric and gastro-esophageal junction (GEJ) adenocarcinoma
Shah, Manish A., Muro, Kei, Shitara, Kohei, Tebbutt, Niall C., Bang, Yung-Jue, Lordick, Florian, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
CanStem111P trial: A phase III study of napabucasin (BBI-608) plus nab-paclitaxel (nab-PTX) with gemcitabine (gem) in adult patients with metastatic pancreatic adenocarcinoma (mPDAC)
Bekaii-Saab, Tanios S., Li, Chung-Pin, Okusaka, Takuji, O'Neil, Bert H., Reni, Michele, Tabernero, Josep, Qin, Shukui, Van Cutsem, Eric, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
BBI608-201GBM: A phase Ib/II clinical study of napabucasin (BBI608) in combination with temozolomide (TMZ) for adult patients with recurrent glioblastoma (GBM)
Mason, Warren P., de Robles, Paula, Borodyansky, Laura, Hitron, Matthew, Ortuzar, Waldo Feliu, Khan, Waheed, Xu, Bo, Li, Wei, Li, Youzhi, Li, C J
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
CanStem303C trial: A phase III study of napabucasin (BBI-608) in combination with 5-fluorouracil (5-FU), leucovorin, irinotecan (FOLFIRI) in adult patients with previously treated metastatic colorectal cancer (mCRC)
Grothey, Axel, Shah, Manish A., Yoshino, Takayuki, Van Cutsem, Eric, Taieb, Julien, Xu, Ruihua, Tebbutt, Niall C., Falcone, Alfredo, Cervantes, Andres, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Phase Ib study of cancer stem cell (CSC) pathway inhibitor BBI-608 administered in combination with FOLFIRI with and without bevacizumab (Bev) in patients (pts) with advanced colorectal cancer (CRC)
Hubbard, Joleen Marie, O'Neil, Bert H., Jonker, Derek J., Halfdanarson, Thorvardur Ragnar, Starodub, Alexander, Grothey, Axel, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Cryoglobulin Levels Are a Marker of Clinical Improvement in Interferon and Ribavirin-Induced Symptomatic Cryoglobulinemia: 1029
Jouhourian, Caroline, Gonzalez, Angel, Morine, Kevin, Borodyansky, Laura, Lee, Hannah
Published in The American journal of gastroenterology (01.10.2012)
Published in The American journal of gastroenterology (01.10.2012)
Get full text
Journal Article
A phase Ib study of BBI608 in combination with FOLFIRI with and without bevacizumab in patients (pts) with advanced colorectal cancer (CRC)
Hubbard, Joleen Marie, Jonker, Derek J., O'Neil, Bert H., Halfdanarson, Thorvardur Ragnar, Grothey, Axel, Li, Youzhi, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
The BRIGHTER trial: A phase III randomized double-blind study of BBI608 + weekly paclitaxel versus placebo (PBO) + weekly paclitaxel in patients (pts) with pretreated advanced gastric and gastro-esophageal junction (GEJ) adenocarcinoma
Shah, Manish A., Muro, Kei, Shitara, Kohei, Tebbutt, Niall C., Bang, Yung-Jue, Lordick, Florian, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
A phase Ib study of cancer stem cell (CSC) pathway inhibitor BBI-608 in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic ductal adenocarcinoma (mPDAC)
Shahda, Safi, El-Rayes, Bassel F., O'Neil, Bert H., Starodub, Alexander, Hanna, Wahid Tewfik, Borodyansky, Laura, Oh, Cindy, Li, Chiang, Bekaii-Saab, Tanios S.
Published in Journal of clinical oncology (01.02.2016)
Published in Journal of clinical oncology (01.02.2016)
Get full text
Journal Article
Phase 1b/2 trial of cancer stemness inhibitor napabucasin (NAPA) + nab-paclitaxel (nPTX) and gemcitabine (Gem) in metastatic pancreatic adenocarcinoma (mPDAC)
Bekaii-Saab, Tanios S., Starodub, Alexander, El-Rayes, Bassel F., Shahda, Safi, O'Neil, Bert H., Noonan, Anne M., Shaib, Walid Labib, Hanna, Wahid Tewfik, Mikhail, Sameh, Neki, Anterpreet S., Chang, Yue, Dai, Xiaoshu, Li, Wei, Brooks, Emily, Oh, Cindy, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
The BRIGHTER trial: A phase 3 randomized double-blind study of napabucasin (NAPA) plus paclitaxel (PTX) versus placebo (PBO) plus PTX in patients (pts) with pretreated advanced gastric and gastroesophageal junction (GEJ) adenocarcinoma
Shah, Manish A., Shitara, Kohei, Lordick, Florian, Bang, Yung-Jue, Tebbutt, Niall C., Metges, Jean-Philippe, Muro, Kei, Shen, Lin, Tjulandin, Sergei, Hays, John L., Xu, Rui-hua, Fontaine, Marilyn, Brooks, Emily, Xu, Bo, Li, Wei, Li, Chiang, Borodyansky, Laura, Van Cutsem, Eric
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
BBI608-224: A phase Ib/II study of cancer stemness inhibitor napabucasin (BBI-608) administered with panitumumab in KRAS wild-type patients with metastatic colorectal cancer
Larson, Tim, Ortuzar, Waldo Feliu, Bekaii-Saab, Tanios S., Becerra, Carlos, Ciombor, Kristen Keon, Hubbard, Joleen Marie, Edenfield, William Jeffery, Shao, Spencer H., Grothey, Axel, Borodyansky, Laura, Xu, Bo, Li, Wei, Li, Youzhi, Li, Chiang, Khan, Waheed
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
Cancer stemness inhibition and chemosensitization: Phase 1b/II study of cancer stemness inhibitor napabucasin (BBI-608) with FOLFIRI +/- bevacizumab (Bev) administered to colorectal cancer (CRC) patients (pts)
Bendell, Johanna C., O'Neil, Bert H., Starodub, Alexander, Jonker, Derek J., Halfdanarson, Thorvardur Ragnar, Edenfield, William Jeffery, El-Rayes, Bassel F., Hubbard, Joleen Marie, Pitot, Henry C., Hobday, Timothy J., Li, Youzhi, Gao, Yuan, Grothey, Axel, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (01.02.2017)
Published in Journal of clinical oncology (01.02.2017)
Get full text
Journal Article
A phase Ib extension study of cancer stemness inhibitor BB608 (napabucasin) in combination with gemcitabine and nab-paclitaxel (nab-PTX) in patients (pts) with metastatic pancreatic cancer
El-Rayes, Bassel F., Shahda, Safi, Starodub, Alexander, O'Neil, Bert H., Hanna, Wahid Tewfik, Shaib, Walid Labib, Oh, Cindy, Li, Wei, Li, Youzhi, Borodyansky, Laura, Li, Chiang, Bekaii-Saab, Tanios S.
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article
Phase 1b extension study of cancer stemness inhibitor BB608 (napabucasin) administered in combination with FOLFIRI +/- bevacizumab (Bev) in patients (pts) with advanced colorectal cancer (CRC)
O'Neil, Bert H., Hubbard, Joleen Marie, Starodub, Alexander, Jonker, Derek J., Edenfield, William Jeffery, El-Rayes, Bassel F., Halfdanarson, Thorvardur Ragnar, Ramanathan, Ramesh K., Pitot, Henry C., Britten, Carolyn D., Adesunloye, Bamidele, Grothey, Axel, Borodyansky, Laura, Li, Chiang
Published in Journal of clinical oncology (20.05.2016)
Published in Journal of clinical oncology (20.05.2016)
Get full text
Journal Article